Empagliflozin in Pulmonary Arterial Hypertension
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:August 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:August 1, 2023Recruiting
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:April 16, 2019Completed
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:July 10, 2020Completed
Condition(s):Idiopathic Pulmonary Arterial Hypertension.Last Updated:December 30, 2015Withdrawn
Condition(s):Pulmonary Arterial Hypertension; Connective Tissue DiseasesLast Updated:June 29, 2023Recruiting
Condition(s):HypertensionLast Updated:August 21, 2012Terminated
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:March 24, 2008Completed
Condition(s):Idiopathic Pulmonary Arterial HypertensionLast Updated:February 2, 2011Unknown status
Condition(s):Hypertension, PulmonaryLast Updated:November 14, 2018Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:February 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.